FindTrial
Sign In

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-004030-33-FR
Enrollment
Unknown
Registered
2011-11-10
Start date
2011-12-13
Completion date
Unknown
Last updated
2016-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.0 Level: LLT Classification code 10054095 Term: Neuropathic pain System Organ Class: 10029205 - Nervous system disorders

Interventions

Trade Name: EBIXA 10mg Product Name: EBIXA 10mg Pharmaceutical Form: Tablet INN or Proposed INN: MEMANTINE CAS Number: 19982-08-2 Concentration unit: mg milligram(s) Concentration type: equal Concentr

Sponsors

CHU de Clermont-Ferrand
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 30 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 10

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

France

Contacts

Public ContactPatrick LACARIN

CHU de Clermont-Ferrand

placarin@chu-clermontferrand.fr0033473751195

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026